We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Streamline Antibiotic Development; Combat Resistance
FDA to Streamline Antibiotic Development; Combat Resistance
July 19, 2013
The FDA is proposing four drug development approaches that it hopes will help streamline and incentivize development of drugs for patients with antibacterial drug-resistant infections.